XDH and hyperuricemia: With regard to renal protection by xanthine oxidase inhibitors, several reviews have concluded that there is insufficient evidence to support the renoprotective effects of urate-lowering agents in CKD patients with hyperuricemia, but some specific patients groups may benefit from lowering their uric acid levels (6, 7, 69–71).